These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21330406)

  • 1. Hormone depletion-insensitivity of prostate cancer cells is supported by the AR without binding to classical response elements.
    Gonit M; Zhang J; Salazar Md; Cui H; Shatnawi A; Trumbly R; Ratnam M
    Mol Endocrinol; 2011 Apr; 25(4):621-34. PubMed ID: 21330406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.
    Guo Z; Yang X; Sun F; Jiang R; Linn DE; Chen H; Chen H; Kong X; Melamed J; Tepper CG; Kung HJ; Brodie AM; Edwards J; Qiu Y
    Cancer Res; 2009 Mar; 69(6):2305-13. PubMed ID: 19244107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells.
    Li TH; Zhao H; Peng Y; Beliakoff J; Brooks JD; Sun Z
    Nucleic Acids Res; 2007; 35(8):2767-76. PubMed ID: 17426117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling truncated AR expression in a natural androgen responsive environment and identification of RHOB as a direct transcriptional target.
    Tsai HC; Boucher DL; Martinez A; Tepper CG; Kung HJ
    PLoS One; 2012; 7(11):e49887. PubMed ID: 23209612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth.
    Wang Q; Li W; Liu XS; Carroll JS; Jänne OA; Keeton EK; Chinnaiyan AM; Pienta KJ; Brown M
    Mol Cell; 2007 Aug; 27(3):380-92. PubMed ID: 17679089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer.
    Kim Y; Kim J; Jang SW; Ko J
    Oncogene; 2015 Jan; 34(2):226-36. PubMed ID: 24441043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells.
    Levina E; Ji H; Chen M; Baig M; Oliver D; Ohouo P; Lim CU; Schools G; Carmack S; Ding Y; Broude EV; Roninson IB; Buttyan R; Shtutman M
    Oncotarget; 2015 May; 6(15):13088-104. PubMed ID: 26036626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paired box 2 upregulates androgen receptor gene expression in androgen-independent prostate cancer.
    Ito S; Ueda T; Ueno A; Nakagawa H; Taniguchi H; Hongo F; Kamoi K; Okihara K; Kawauchi A; Miki T
    FEBS J; 2014 Oct; 281(19):4506-18. PubMed ID: 25132193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.
    Schweizer L; Rizzo CA; Spires TE; Platero JS; Wu Q; Lin TA; Gottardis MM; Attar RM
    BMC Cell Biol; 2008 Jan; 9():4. PubMed ID: 18218096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor action in hormone-dependent and recurrent prostate cancer.
    Agoulnik IU; Weigel NL
    J Cell Biochem; 2006 Oct; 99(2):362-72. PubMed ID: 16619264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel androgen receptor target genes in prostate cancer.
    Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
    Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of GnRH type II is regulated by the androgen receptor in prostate cancer.
    Darby S; Stockley J; Khan MM; Robson CN; Leung HY; Gnanapragasam VJ
    Endocr Relat Cancer; 2007 Sep; 14(3):613-24. PubMed ID: 17914092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen deprivation increases p300 expression in prostate cancer cells.
    Heemers HV; Sebo TJ; Debes JD; Regan KM; Raclaw KA; Murphy LM; Hobisch A; Culig Z; Tindall DJ
    Cancer Res; 2007 Apr; 67(7):3422-30. PubMed ID: 17409453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular regulation of androgen action in prostate cancer.
    Dehm SM; Tindall DJ
    J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen.
    Weber H; Ruoff R; Garabedian MJ
    PLoS Genet; 2021 Jan; 17(1):e1008540. PubMed ID: 33513133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
    Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
    Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
    Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
    Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin.
    Toropainen S; Malinen M; Kaikkonen S; Rytinki M; Jääskeläinen T; Sahu B; Jänne OA; Palvimo JJ
    Nucleic Acids Res; 2015 Jan; 43(2):848-61. PubMed ID: 25552417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling.
    Köhler A; Demir U; Kickstein E; Krauss S; Aigner J; Aranda-Orgillés B; Karagiannidis AI; Achmüller C; Bu H; Wunderlich A; Schweiger MR; Schaefer G; Schweiger S; Klocker H; Schneider R
    Mol Cancer; 2014 Jun; 13():146. PubMed ID: 24913494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.